1. Home
  2. OSCR vs RGEN Comparison

OSCR vs RGEN Comparison

Compare OSCR & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oscar Health Inc.

OSCR

Oscar Health Inc.

HOLD

Current Price

$28.19

Market Cap

7.1B

Sector

Finance

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$131.96

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSCR
RGEN
Founded
2012
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Accident &Health Insurance
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
6.6B
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
OSCR
RGEN
Price
$28.19
$131.96
Analyst Decision
Hold
Buy
Analyst Count
8
12
Target Price
$16.88
$167.67
AVG Volume (30 Days)
4.7M
1.1M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
286.96
EPS
2.07
0.15
Revenue
$11,701,427,000.00
$141,236,000.00
Revenue This Year
$63.89
$14.30
Revenue Next Year
$5.30
$14.52
P/E Ratio
$14.02
$917.33
Revenue Growth
27.50
35.10
52 Week Low
$10.69
$100.99
52 Week High
$33.10
$175.77

Technical Indicators

Market Signals
Indicator
OSCR
RGEN
Relative Strength Index (RSI) 46.80 44.43
Support Level $27.89 $127.63
Resistance Level $32.71 $141.46
Average True Range (ATR) 1.59 6.48
MACD -0.50 -1.76
Stochastic Oscillator 10.53 24.02

Price Performance

Historical Comparison
OSCR
RGEN

About OSCR Oscar Health Inc.

Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry. Oscar operates as one segment to sell insurance to individuals, families and employees through the federal and state-run healthcare exchanges formed in conjunction with the Patient Protection and Affordable Care Act (ACA) and leverages its technology platform to provide services via its Oscar offering.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: